resiquimod has been researched along with 1,2-dipalmitoylphosphatidylcholine in 1 studies
| Studies (resiquimod) | Trials (resiquimod) | Recent Studies (post-2010) (resiquimod) | Studies (1,2-dipalmitoylphosphatidylcholine) | Trials (1,2-dipalmitoylphosphatidylcholine) | Recent Studies (post-2010) (1,2-dipalmitoylphosphatidylcholine) |
|---|---|---|---|---|---|
| 465 | 14 | 318 | 4,158 | 20 | 1,262 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barinaga, G; Carter, D; King, DF; Mann, JF; McKay, PF; Shattock, RJ | 1 |
1 other study(ies) available for resiquimod and 1,2-dipalmitoylphosphatidylcholine
| Article | Year |
|---|---|
TLR4 and TLR7/8 Adjuvant Combinations Generate Different Vaccine Antigen-Specific Immune Outcomes in Minipigs when Administered via the ID or IN Routes.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Adjuvants, Immunologic; Administration, Intranasal; AIDS Vaccines; Animals; Antibody Affinity; Antibody Specificity; Antigens; Dose-Response Relationship, Immunologic; Drug Combinations; env Gene Products, Human Immunodeficiency Virus; Female; HIV Antibodies; Imidazoles; Immunity, Innate; Immunity, Mucosal; Immunization, Secondary; Immunoglobulin G; Injections, Intradermal; Lipid A; Models, Animal; Nasal Mucosa; Neutralization Tests; Organ Specificity; Swine; Swine, Miniature; Toll-Like Receptor 4; Toll-Like Receptor 7; Toll-Like Receptor 8; Vaccination; Vagina | 2016 |